Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2025 Earnings Call Transcript August 12, 2025
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $1.21 EPS, expectations were $1.43.
Operator: Good afternoon, and thank you for joining Zevra’s Second Quarter 2025 Financial Results and Corporate Update Conference Call. Today’s call is being recorded and will be available via the Investor Relations section of the company’s website later today. The host for today’s call is Nichol...
